|Articles|June 1, 2001
- Pharmaceutical Executive-06-01-2001
- Volume 0
- Issue 0
Emotion - The New Brand Integrator
Author(s)Gil Bashe
Driven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by most marketing and communication departments-the power of emotion.
Advertisement
Articles in this issue
over 24 years ago
Industry Under Investigationover 24 years ago
For Love of the Gameover 24 years ago
Field of Dreamsover 24 years ago
Workshop: Access Optionsover 24 years ago
Emotion - The New Brand Integratorover 24 years ago
Rx-to-OTC: Unwanted Attentionover 24 years ago
Emotion - Biotech Renaissance Manover 24 years ago
Relocation: Coming to Americaover 24 years ago
Stocks: Catching the Market Bluesover 24 years ago
Gathering LightNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
